Patient Support for Horizon Therapeutics

As a UI Designer at Epsilon (a Publicis Groupe-owned company), I led the website redesign for KRYSTEXXA (pegloticase), a treatment for chronic gout in adults unresponsive to conventional therapies. The redesigned platform focused on improving usability, accessibility, and patient engagement by streamlining navigation and offering clear, personalized support resources. Key enhancements included simplified onboarding, intuitive navigation, and accessible support tools, resulting in a 50% increase in monthly users (from 20,000 to 30,000) and a 15% boost in conversion rates. Additionally, the user-centered design led to a 15% increase in treatment initiations and a 50% rise in patient support requests, reflecting greater satisfaction and improved healthcare outcomes.